Aptevo Therapeutics (APVO) EBITDA Margin (QoQ) (2015 - 2022)
Aptevo Therapeutics (APVO) EBITDA Margin (QoQ) (2015 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Aptevo Therapeutics | 3.30 Mn | -6.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -6,995.00 |
| Dec 31, 2021 | 4,319.00 |
| Sep 30, 2021 | 3,056.00 |
| Jun 30, 2021 | 10,052.00 |
| Mar 31, 2021 | 285.00 |
| Dec 31, 2020 | 13,957.00 |
| Sep 30, 2020 | 101,218.00 |
| Dec 31, 2019 | 3,929.00 |
| Sep 30, 2019 | 4,805.00 |
| Jun 30, 2019 | -1,230.00 |
| Sep 30, 2018 | 1,041.00 |
| Jun 30, 2018 | 9,354.00 |
| Sep 30, 2017 | 24,780.00 |
| Jun 30, 2017 | 15,088.00 |
| Mar 31, 2017 | -40,038.00 |
| Dec 31, 2016 | 304,871.00 |
| Sep 30, 2016 | -308,823.00 |
| Jun 30, 2016 | 3,448.00 |
| Mar 31, 2016 | 6,235.00 |
| Dec 31, 2015 | -2,229.00 |